🇺🇸 FDA
Patent

US 8546398

Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

granted A61KA61K31/505A61K31/506

Quick answer

US patent 8546398 (Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/505, A61K31/506, A61P, A61P1/04